ANDA 77756, held by Impax Labs Inc. Levalbuterol Hydrochloride.
As of Nov 16, 2026, ANDA 77756 (Levalbuterol Hydrochloride), held by Impax Labs Inc, was first approved by FDA on Apr 9, 2008, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 9, 2008 | Original application | Approved | None posted |
| Levalbuterol HydrochlorideEQ 0.021% BASE · solution;inhalation | Levalbuterol Hydrochloride | Rx |
| Levalbuterol HydrochlorideEQ 0.042% BASE · solution;inhalation | Levalbuterol Hydrochloride | Rx |
| Levalbuterol HydrochlorideEQ 0.0103% BASE · solution;inhalation | Levalbuterol Hydrochloride | Rx |
| Dec 27, 2017 | Supplement 3Labeling · Standard review | Approved | None posted |
| Apr 9, 2008 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters